Respiratory Therapy · Therapeutic Intervention
Respiratory Pharmacology and Specialty Gas Concepts
On this page 7 sections
In 30 seconds
Inhaled bronchodilators relax airway smooth muscle: short-acting beta-2 agonists (SABA Short-acting beta-2 agonist (albuterol, levalbuterol) Full entry →; albuterol, levalbuterol) and short-acting muscarinic antagonists (SAMA Short-acting muscarinic antagonist (ipratropium) Full entry →; ipratropium) act quickly for acute relief, while long-acting beta-2 agonists (LABA Long-acting beta-2 agonist (salmeterol, formoterol) Full entry →; salmeterol, formoterol) and long-acting muscarinic antagonists (LAMA Long-acting muscarinic antagonist (tiotropium) Full entry →; tiotropium) provide maintenance control. Inhaled corticosteroids (fluticasone, budesonide) reduce airway inflammation, and mucolytics (acetylcysteine, dornase alfa) thin secretions. Specialty therapies — Inhaled nitric oxide Selective pulmonary vasodilator Full entry →, Heliox Helium-oxygen mixture (80/20, 70/30) Full entry →, and Prostacyclins Pulmonary vasodilators (epoprostenol, iloprost, treprostinil) Full entry → — address specific pulmonary vascular or airflow problems, and the NAVEL Naloxone, Atropine, Vasopressin/diazepam, Epinephrine, Lidocaine Full entry → mnemonic recalls emergency agents (naloxone, atropine, vasopressin, epinephrine, lidocaine).
Why this matters
Respiratory pharmacology requires precise recognition of drug class, mechanism, duration, and monitoring needs. The therapist assesses response and monitors for side effects but does not independently select, dose, or administer beyond ordered, protocol-directed practice. This note is educational only and does not authorize any clinical action. All medication names, indications, routes, and any dose or administration considerations must be verified in the current NBRC detailed content outline, candidate handbook, AARC clinical practice guidelines, current ACLS/PALS/NRP guidelines, facility protocols, state licensure requirements, provider orders, and manufacturer labeling. Emergent findings (severe bronchospasm unresponsive to initial therapy, signs of anaphylaxis, or deterioration during specialty-gas therapy) require immediate escalation to qualified clinicians or activation of local emergency response.
The college version
1. Bronchodilators: SABA, LABA, SAMA, LAMA
Beta-2 agonists stimulate beta-2 receptors on airway smooth muscle, causing bronchodilation. SABA — albuterol and levalbuterol (the active R-isomer of albuterol) — have rapid onset and short duration, making them the relievers for acute bronchospasm. LABA — salmeterol and formoterol — have slower onset but 12-hour-or-longer duration, so they are maintenance agents, never sole acute rescue. Muscarinic antagonists block acetylcholine at muscarinic receptors, reducing cholinergic bronchoconstriction and secretions. SAMA — ipratropium — has slower onset than albuterol but a complementary mechanism, so it is often combined with a SABA in acute exacerbations. LAMA — tiotropium — provides once-daily bronchodilation for COPD maintenance. The technologist recognizes each class, its onset and duration, and its place in acute versus maintenance therapy.
2. Inhaled Corticosteroids and Mucolytics
Inhaled corticosteroids (ICS) — fluticasone and budesonide — suppress inflammatory cells and mediators, reducing airway inflammation over days to weeks; they are controllers, not rapid bronchodilators. Key exam points: ICS address the inflammatory component of asthma (and COPD when indicated), and rinsing the mouth after use reduces local effects such as oral thrush. Mucolytics alter mucus for easier clearance. Acetylcysteine (N-acetylcysteine, NAC) breaks disulfide bonds in mucus, thinning tenacious secretions; it also has antioxidant and specific antidote roles. Dornase alfa is a recombinant enzyme that cuts extracellular DNA from neutrophils in infected mucus, especially effective in cystic fibrosis where DNA thickens sputum. Both improve clearance but can irritate the airway (acetylcysteine can cause bronchospasm), so they are used selectively and monitored.
3. Specialty Gases and Emergency Instillation Agents
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator: inhaled into ventilated alveoli, it relaxes the vessels supplying those units, improving ventilation-perfusion (V/Q) matching and lowering pulmonary vascular resistance (used in persistent pulmonary hypertension of the newborn, select ARDS cases, and post-cardiac surgery). It requires NO2 and methemoglobin monitoring and careful weaning (abrupt discontinuation risks rebound pulmonary hypertension). Heliox is a helium-oxygen mixture, typically 80/20 or 70/30; helium's low density reduces airflow resistance and eases gas through narrowed airways (upper airway obstruction, stridor, severe asthma), but flowmeter readings must be corrected because actual flow exceeds what a standard oxygen flowmeter indicates. Prostacyclins — epoprostenol, iloprost, and treprostinil — are potent pulmonary vasodilators for pulmonary arterial hypertension; the inhaled route targets ventilated regions, improving V/Q matching while limiting systemic hypotension. The NAVEL mnemonic recalls emergency agents historically instilled through an endotracheal tube: Naloxone (reverses opioid overdose), Atropine (treats symptomatic bradycardia), Vasopressin (a vasopressor; some versions list diazepam/"Valium," a benzodiazepine for seizures), Epinephrine (the primary vasopressor in cardiac arrest and anaphylaxis), and Lidocaine (an antiarrhythmic). Current practice emphasizes intravenous/intraosseous routes, so these are conceptual exam points whose doses and routes must follow current guidelines.
How it works
- Beta-2 agonists bind beta-2 receptors, raising cAMP and relaxing airway smooth muscle to dilate airways.
- Muscarinic antagonists block acetylcholine at muscarinic receptors, reducing cholinergic bronchoconstriction and secretions.
- Corticosteroids suppress inflammatory cells and mediators, reducing airway swelling over days to weeks.
- Mucolytics break chemical bonds (acetylcysteine cleaves disulfide bonds; dornase alfa digests DNA) to thin sputum.
- iNO and prostacyclins relax pulmonary vascular smooth muscle, lowering pulmonary vascular resistance and improving V/Q matching.
- Heliox's low density reduces resistance and turbulence, helping gas pass through a narrowed airway.
Common confusions
| Do not confuse | With | Difference |
|---|---|---|
| SABA | LABA | SABA is rapid-onset rescue; LABA is slow-onset maintenance |
| SAMA | LAMA | SAMA is short-acting (ipratropium); LAMA is long-acting (tiotropium) |
| Inhaled corticosteroid | Bronchodilator | ICS reduces inflammation over days; bronchodilators relax muscle in minutes |
| Acetylcysteine | Dornase alfa | Acetylcysteine breaks disulfide bonds; dornase alfa digests DNA |
| Vasopressin | Diazepam | Both appear as "V" in some NAVEL versions; vasopressin is a vasopressor, diazepam a benzodiazepine |
Memory aids
"S-L-S-L, I-M, H-N-P, N-A-V-E-L" — the drug ladder: SABA and SAMA act Short; LABA and LAMA act Long; ICS calms Inflammation; Mucolytics thin Mucus; Heliox, Nitric oxide, and Prostacyclins are specialty gases; N-A-V-E-L (Naloxone, Atropine, Vasopressin, Epinephrine, Lidocaine) recalls emergency agents.
Quick review
Topic Recap
Inhaled bronchodilators divide by mechanism and duration: SABA (albuterol, levalbuterol) and SAMA (ipratropium) give short-acting relief, while LABA (salmeterol, formoterol) and LAMA (tiotropium) provide long-acting maintenance. Inhaled corticosteroids (fluticasone, budesonide) control inflammation and are not quick relievers; mucolytics (acetylcysteine, dornase alfa) thin secretions by different mechanisms. Specialty therapies — inhaled nitric oxide, heliox, and prostacyclins — target pulmonary vascular resistance or narrowed-airway flow and carry specific monitoring needs (methemoglobin/NO2, flowmeter correction). The NAVEL mnemonic recalls emergency agents and their roles. The technologist's role is recognition, monitoring, and escalation, never independent prescribing.
Knowledge Check
- Why is a LABA like salmeterol not used as the sole agent for rapid relief of an acute asthma attack?
- What two substances must be monitored during inhaled nitric oxide therapy?
- Why do heliox mixtures require flowmeter correction?
- What distinguishes acetylcysteine from dornase alfa in mechanism of action?
- In the NAVEL mnemonic, which agent is the primary vasopressor in cardiac arrest?
Answers and Rationales
- Its onset is slow and its role is long-acting maintenance. Salmeterol is designed for 12-hour control; acute attacks need a rapid-onset SABA such as albuterol or levalbuterol.
- Methemoglobin and nitrogen dioxide (NO2). Nitric oxide can oxidize hemoglobin to methemoglobin and react with oxygen to form toxic NO2, so both are tracked during therapy.
- Helium's low density causes actual gas flow to be higher than a standard oxygen flowmeter indicates. A calibrated correction factor or dedicated helium flowmeter is required.
- Acetylcysteine breaks disulfide bonds in mucus, while dornase alfa is an enzyme that digests DNA released from neutrophils — the latter is especially useful in cystic fibrosis sputum.
- Epinephrine. It is the primary vasopressor in cardiac arrest and is also used in anaphylaxis; atropine addresses bradycardia and naloxone reverses opioid overdose.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of the airways as garden hoses that can be squeezed shut. Bronchodilators relax the squeezing muscles so the hose opens. Short-acting ones (SABA like albuterol, SAMA like ipratropium) work in minutes and last a few hours — good for an acute attack. Long-acting ones (LABA like salmeterol, LAMA like tiotropium) open slowly and stay open all day — good for prevention, not emergencies.
Some airway problems are swelling and irritation inside the hose wall, not squeezing. Inhaled corticosteroids (fluticasone, budesonide) calm that inflammation over days to weeks, so they are controllers, not quick relievers. Mucolytics act like a solvent that thins thick glue so mucus drains. Specialty gases are specialized tools: heliox is a thinner-than-air gas that flows more easily through a partly squeezed hose, while inhaled nitric oxide and prostacyclins relax only the lungs' blood vessels.
Where it stops being exact: the hose hides that each drug hits a specific receptor with a specific onset, duration, and side-effect/monitoring profile (nitric oxide requires methemoglobin and NO2 monitoring). None are chosen or dosed by analogy — selection, dosing, and routes are directed by qualified clinicians; the technologist recognizes classes, expected effects, and monitoring needs.
Simple Example
A person with asthma arrives wheezing. They receive a SABA (albuterol), which relaxes the airways within minutes, plus a SAMA (ipratropium) to open them by a second pathway. After the attack, the long-term plan adds a daily inhaled corticosteroid (fluticasone) to reduce inflammation and a long-acting bronchodilator (salmeterol or tiotropium) for maintenance — these long-acting agents are not used as quick relief during an attack.
Worked example
- Classify by mechanism and duration. Identify whether a drug is a beta-2 agonist, muscarinic antagonist, corticosteroid, or mucolytic, and whether it is short- or long-acting. Why: mechanism and duration determine acute-relief versus maintenance appropriateness.
- Match the drug to the problem. Acute bronchospasm calls for a SABA (often plus a SAMA); chronic inflammatory control calls for an ICS plus a LABA/LAMA; thick secretions suggest a mucolytic. Why: using a controller for acute relief (or a reliever as sole long-term control) is a classic error.
- Anticipate monitoring needs. For iNO, anticipate methemoglobin and NO2 monitoring; for heliox, anticipate flowmeter correction; for ICS, anticipate mouth rinsing; for acetylcysteine, anticipate possible bronchospasm. Why: each therapy has a signature monitoring or side-effect profile the exam tests.
- Recognize emergency-agent roles. Identify which NAVEL agent fits the problem (epinephrine for arrest, naloxone for suspected opioid overdose). Why: rapid recognition supports team communication and escalation.
- Escalate for adjustment. Report inadequate response, side effects, or a drug-condition mismatch to the prescribing clinician. Why: selection and dosing are clinician-directed; the technologist observes, documents, and escalates.
Key takeaways
- High yield: SABA (albuterol, levalbuterol) = quick relief; LABA (salmeterol, formoterol) = maintenance only, never sole acute rescue.
- High yield: ipratropium (SAMA) is often combined with a SABA in acute exacerbations because it acts by a second, complementary pathway.
- High yield: Inhaled corticosteroids are controllers, not relievers; rinse the mouth after use to reduce oral thrush risk.
- High yield: Acetylcysteine breaks disulfide bonds but can cause bronchospasm; dornase alfa digests DNA and is especially useful in cystic fibrosis.
- High yield: Inhaled nitric oxide requires methemoglobin and NO2 monitoring and careful weaning (rebound pulmonary hypertension risk).
- High yield: Heliox (80/20 or 70/30) requires flowmeter correction because helium makes actual flow higher than indicated.
- High yield: Prostacyclins (epoprostenol, iloprost, treprostinil) are pulmonary vasodilators for pulmonary arterial hypertension.
- High yield: NAVEL = Naloxone, Atropine, Vasopressin (or diazepam), Epinephrine, Lidocaine.
Study tools & related lessonsYou’ll learn to · Key vocabulary · Related
You’ll learn to
- Classify inhaled bronchodilators (SABA, LABA, SAMA, LAMA) by mechanism, duration, and example agents.
- Describe inhaled corticosteroids and mucolytics, including their roles and example drugs.
- Explain specialty gas and advanced therapies: inhaled nitric oxide, heliox, and prostacyclins.
- Recognize emergency instillation agents (the NAVEL mnemonic) and their resuscitation roles.
Key vocabulary
- SABA
- Short-acting beta-2 agonist (albuterol, levalbuterol)
- LABA
- Long-acting beta-2 agonist (salmeterol, formoterol)
- SAMA
- Short-acting muscarinic antagonist (ipratropium)
- LAMA
- Long-acting muscarinic antagonist (tiotropium)
- Inhaled corticosteroid
- Anti-inflammatory controller (fluticasone, budesonide)
- Mucolytic
- Thins mucus (acetylcysteine, dornase alfa)
- Inhaled nitric oxide
- Selective pulmonary vasodilator
- Heliox
- Helium-oxygen mixture (80/20, 70/30)
- Prostacyclins
- Pulmonary vasodilators (epoprostenol, iloprost, treprostinil)
- NAVEL
- Naloxone, Atropine, Vasopressin/diazepam, Epinephrine, Lidocaine
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.
